[1] |
Tollefson MM, Crowson CS, McEvoy MT, et al. Incidence of psoriasis in children: a population⁃based study[J]. J Am Acad Dermatol, 2010,62(6):979⁃987. doi: 10.1016/j.jaad.2009.07.029.
|
[2] |
中华医学会皮肤性病学分会银屑病学组, 中华医学会皮肤性病学分会儿童学组. 中国儿童银屑病诊疗专家共识(2021)[J]. 中华皮肤科杂志, 2021,54(7):559⁃581. doi: 10.35541/cjd.20201065.
|
[3] |
江载芳, 申昆玲,沈颖. 诸福棠实用儿科学[M]. 北京: 人民卫生出版, 2015:3⁃4.
|
[4] |
Harper J, Oranje AP. Harper′s textbook of pediatric dermatology[M]. Singapore: John Wiley & Sons, 2019.
|
[5] |
中华人民共和国卫生部. 糖皮质激素类药物临床应用指导原则[EB/OL]. (2011⁃02⁃16). http://www.gov.cn/gzdt/2011-02/24/content_1810219.htm.
|
[6] |
Balato A, Scalvenzi M, Cirillo T, et al. Psoriasis in children: a review[J]. Curr Pediatr Rev, 2015,11(1):10⁃26. doi: 10.2174/1573400511666150504125456.
|
[7] |
全国银屑病流行调查组. 全国1984年银屑病流行调查报告[J]. 中华皮肤科杂志, 1986,19(5):253⁃261.
|
[8] |
丁晓岚, 王婷琳, 沈佚葳, 等. 中国六省市银屑病流行病学调查[J]. 中国皮肤性病学杂志, 2010,24(7):598⁃601.
|
[9] |
Tollefson MM. Diagnosis and management of psoriasis in children[J]. Pediatr Clin North Am, 2014,61(2):261⁃277. doi: 10.1016/j.pcl.2013.11.003.
|
[10] |
Fan X, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China[J]. J Eur Acad Dermatol Venereol, 2007,21(6):762⁃765. doi: 10.1111/j.1468⁃3083.2007.02014.x.
|
[11] |
Morris A, Rogers M, Fischer G, et al. Childhood psoriasis: a clinical review of 1262 cases[J]. Pediatr Dermatol, 2001,18(3):188⁃198. doi: 10.1046/j.1525⁃1470.2001.018003188.x.
|
[12] |
Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis[J]. Pediatr Dermatol, 2000,17(3):174⁃178. doi: 10.1046/j.1525⁃1470.2000.01746.x.
|
[13] |
Kwon HH, Na SJ, Jo SJ, et al. Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic[J]. J Dermatol, 2012,39(3):260⁃264. doi: 10.1111/j.1346⁃8138.2011. 01452.x.
|
[14] |
Seyhan M, Coşkun BK, Sağlam H, et al. Psoriasis in childhood and adolescence: evaluation of demographic and clinical features[J]. Pediatr Int, 2006,48(6):525⁃530. doi: 10.1111/j.1442⁃200X.2006.02270.x.
|
[15] |
Shah KN. Diagnosis and treatment of pediatric psoriasis: current and future[J]. Am J Clin Dermatol, 2013,14(3):195⁃213. doi: 10.1007/s40257⁃013⁃0026⁃8.
|
[16] |
Chiam LY, de Jager ME, Giam YC, et al. Juvenile psoriasis in European and Asian children: similarities and differences[J]. Br J Dermatol, 2011,164(5):1101⁃1103. doi: 10.1111/j.1365⁃2133.2010.10196.x.
|
[17] |
Relvas M, Torres T. Pediatric psoriasis[J]. Am J Clin Dermatol, 2017,18(6):797⁃811. doi: 10.1007/s40257⁃017⁃0294⁃9.
|
[18] |
Bronckers IM, Paller AS, van Geel MJ, et al. Psoriasis in children and adolescents: diagnosis, management and comorbidities[J]. Paediatr Drugs, 2015,17(5):373⁃384. doi: 10.1007/s40272⁃015⁃0137⁃1.
|
[19] |
Neuhauser R, Eyerich K, Boehner A. Generalized pustular psoriasis⁃dawn of a new era in targeted immunotherapy[J]. Exp Dermatol, 2020,29(11):1088⁃1096. doi: 10.1111/exd.14171.
|
[20] |
Eisert L, Augustin M, Bach S, et al. S2k guidelines for the treatment of psoriasis in children and adolescents⁃short version part 1[J]. J Dtsch Dermatol Ges, 2019,17(8):856⁃870. doi: 10.1111/ddg.13907.
|
[21] |
Menter A, Cordoro KM, Davis D, et al. Joint American Academy of Dermatology⁃National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients[J]. J Am Acad Dermatol, 2020,82(1):161⁃201. doi: 10.1016/j.jaad.2019.08.049.
|
[22] |
Vogel SA, Yentzer B, Davis SA, et al. Trends in pediatric psoriasis outpatient health care delivery in the United States[J]. Arch Dermatol, 2012,148(1):66⁃71. doi: 10.1001/archdermatol. 2011.263.
|
[23] |
Dogan B, Karabudak O, Harmanyeri Y. Antistreptococcal treatment of guttate psoriasis: a controlled study[J]. Int J Dermatol, 2008,47(9):950⁃952. doi: 10.1111/j.1365⁃4632.2008. 03663.x.
|
[24] |
Owen CM, Chalmers RJ, O′Sullivan T, et al. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis[J]. Br J Dermatol, 2001,145(6):886⁃890. doi: 10. 1046/j.1365⁃2133.2001.04504.x.
|
[25] |
Eisert L, Augustin M, Bach S, et al. S2k guidelines for the treatment of psoriasis in children and adolescents ⁃ Short version part 2[J]. J Dtsch Dermatol Ges, 2019,17(9):959⁃973. doi: 10.1111/ddg.13936.
|
[26] |
中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南(2018完整版)[J]. 中华皮肤科杂志, 2019,52(10):667⁃710. doi: 10.35541/cjd.20190847.
|
[27] |
de Jager ME, de Jong EM, van de Kerkhof PC, et al. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review[J]. J Am Acad Dermatol, 2010,62(6):1013⁃1030. doi: 10.1016/j.jaad.2009.06.048.
|
[28] |
Subedi S, Yu Q, Chen Z, et al. Management of pediatric psoriasis with acitretin: a review[J]. Dermatol Ther, 2018,31(1). doi: 10.1111/dth.12571.
|
[29] |
Bronckers I, Seyger M, West DP, et al. Safety of systemic agents for the treatment of pediatric psoriasis[J]. JAMA Dermatol, 2017,153(11):1147⁃1157. doi: 10.1001/jamadermatol.2017.3029.
|